Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Nov;70(5):989–998. doi: 10.1172/JCI110710

Drug-Antibody-Platelet Interaction in Quinine- and Quinidine-induced Thrombocytopenia

Douglas J Christie 1,2,3, Richard H Aster 1,2,3
PMCID: PMC370311  PMID: 6215430

Abstract

Binding of quinine- and quinidine-dependent antibodies to platelets was studied using an electroimmunoassay to measure platelet-bound IgG. Antibodies from four patients with drug-induced thrombocytopenia differed significantly in their interaction with platelets: association constants for binding to platelets at high drug concentrations ranged from 0.29 to 2.6 × 107 M−1, the maximum number of antibody molecules bound ranged from 36,000 to 161,000/platelet, the amount of drug necessary to achieve half-maximum binding of antibodies to platelets ranged from 2 to 60 μM, and only one of the antibodies cross-reacted with the stereoisomer of the drug to which the patient was sensitized. Binding of the antibodies to platelets was enhanced at the highest achievable molar ratio of drug:antibody, 10,000:1, rather than being inhibited, as would be expected in a conventional, hapten-dependent reaction. The drug-antibody-platelet reaction was unaffected by Factor VIII/von Willebrand protein, nonspecifically aggregated IgG, or heat-labile complement components. After pretreatment with tritiated quinine, platelets retained several hundred thousand molecules of drug each, but failed to bind detectable amounts of antibody. However, platelets treated simultaneously with quinine-dependent antibody and tritiated quinine retained significantly more drug after repeated washes than platelets treated with drug and normal serum.

These findings support the proposition that in quinine- and quinidine-induced thrombocytopenia, drug and antibody combine first in the soluble phase to form a complex, which then binds with high affinity to a receptor on the platelet surface (innocent bystander reaction), and demonstrate that these antibodies are heterogeneous in respect to the amount of drug required to promote their binding to platelets, the number of platelet receptors they recognize, and their binding affinities.

Full text

PDF
989

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACKROYD J. F. Allergic purpura, including purpura due to foods, drugs and infections. Am J Med. 1953 May;14(5):605–632. doi: 10.1016/0002-9343(53)90377-5. [DOI] [PubMed] [Google Scholar]
  2. Aster R. H., Enright S. E. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies. J Clin Invest. 1969 Jul;48(7):1199–1210. doi: 10.1172/JCI106084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bjerrum O. J., Ingild A., Lowenstein H., Weeke B. Carbamylated antibodies used for quantitation of human IgG. A routine method. Scand J Immunol Suppl. 1973;1:145–148. doi: 10.1111/j.1365-3083.1973.tb03795.x. [DOI] [PubMed] [Google Scholar]
  4. Croft J. D., Jr, Swisher S. N., Jr, Gilliland B. C., Bakemeier R. F., Leddy J. P., Weed R. I. Coombs'-test positivity induced by drugs. Mechanisms of immunologic reactions and red cell destruction. Ann Intern Med. 1968 Jan;68(1):176–187. doi: 10.7326/0003-4819-68-1-176. [DOI] [PubMed] [Google Scholar]
  5. Glode L. M., Montgomery R. R., Smith C. G., Link D. B. Use of monoclonal antibody to increase sensitivity and specificity in quantitative immunodiffusion assays. J Immunol Methods. 1982;48(1):13–22. doi: 10.1016/0022-1759(82)90205-8. [DOI] [PubMed] [Google Scholar]
  6. HILL T. L. Immunoreactions involving platelets. II. Theoretical analysis of the model. J Exp Med. 1958 May 1;107(5):691–695. doi: 10.1084/jem.107.5.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hirschfeld D. S., Ueda C. T., Rowland M., Scheinman M. M. Clinical and electrophysiological effects of intravenous quinidine in man. Br Heart J. 1977 Mar;39(3):309–316. doi: 10.1136/hrt.39.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hosseinzadeh P. K., Firkin B. G., Pfueller S. L. Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia. J Clin Invest. 1980 Oct;66(4):638–645. doi: 10.1172/JCI109899. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  9. Kekomäki R., Rajamäki A., Myllylä G. Detection of quinidine-specific antibodies with platelet 125I-labeled staphylococcal protein A test. Vox Sang. 1980;38(1):12–18. doi: 10.1111/j.1423-0410.1980.tb02324.x. [DOI] [PubMed] [Google Scholar]
  10. Kelton J. G., Meltzer D., Moore J., Giles A. R., Wilson W. E., Barr R., Hirsh J., Neame P. B., Powers P. J., Walker I. Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood. 1981 Sep;58(3):524–529. [PubMed] [Google Scholar]
  11. Kessler K. M., Lowenthal D. T., Warner H., Gibson T., Briggs W., Reidenberg M. M. Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med. 1974 Mar 28;290(13):706–709. doi: 10.1056/NEJM197403282901303. [DOI] [PubMed] [Google Scholar]
  12. Kunicki T. J., Johnson M. M., Aster R. H. Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest. 1978 Sep;62(3):716–719. doi: 10.1172/JCI109181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kunicki T. J., Koenig M. B., Kristopeit S. M., Aster R. H. Direct quantitation of platelet-associated IgG by electroimmunoassay. Blood. 1982 Jul;60(1):54–58. [PubMed] [Google Scholar]
  14. Lizak G. E., Grumet F. C. Storage of reagent platelets for anti-platelet antibody testing in the 51Cr platelet lysis assay. J Clin Pathol. 1979 Feb;32(2):191–192. doi: 10.1136/jcp.32.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MIESCHER P., MIESCHER A. Die Sedormid-Anaphylaxie. Schweiz Med Wochenschr. 1952 Dec 13;82(50):1279–1282. [PubMed] [Google Scholar]
  16. Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  17. Nurden A. T., Dupuis D., Kunicki T. J., Caen J. P. Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Invest. 1981 May;67(5):1431–1440. doi: 10.1172/JCI110172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Petz L. D. Drug-induced immune haemolytic anaemia. Clin Haematol. 1980 Oct;9(3):455–482. [PubMed] [Google Scholar]
  19. Petz L. D., Fundenberg H. H. Immunologic mechanisms in drug-induced cytopenias. Prog Hematol. 1975;9:185–206. [PubMed] [Google Scholar]
  20. Pfueller S. L., Cosgrove L., Firkin B. G., Tew D. Relationship of raised platelet IgG in thrombocytopenia to total platelet protein content. Br J Haematol. 1981 Oct;49(2):293–302. doi: 10.1111/j.1365-2141.1981.tb07226.x. [DOI] [PubMed] [Google Scholar]
  21. Pfueller S. L., Hosseinzadeh P. K., Firkin B. G. Quinine- and quinidine-dependent antiplatelet antibodies. Requirement of factor VIII-related antigen for platelet damage and for in vitro transformation of lymphocytes from patients with drug-induced thrombocytopenia. J Clin Invest. 1981 Mar;67(3):907–910. doi: 10.1172/JCI110109. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  22. SHULMAN N. R. Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex. J Exp Med. 1958 May 1;107(5):665–690. doi: 10.1084/jem.107.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SHULMAN N. R. Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura. J Exp Med. 1958 May 1;107(5):711–729. doi: 10.1084/jem.107.5.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shulman N. R. Immunologic reactions to drugs. N Engl J Med. 1972 Aug 24;287(8):408–409. doi: 10.1056/NEJM197208242870810. [DOI] [PubMed] [Google Scholar]
  25. Sugiura K., Steiner M., Baldini M. Physiological effects of nonimmune platelet associated immunoglobulin G. Thromb Haemost. 1981 Feb 23;45(1):27–33. [PubMed] [Google Scholar]
  26. Young G. A., Vincent P. C. Drug-induced agranulocytosis. Clin Haematol. 1980 Oct;9(3):483–504. [PubMed] [Google Scholar]
  27. Zimmerman T. S., Roberts J., Edgington T. S. Factor-VIII-related antigen: multiple molecular forms in human plasma. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5121–5125. doi: 10.1073/pnas.72.12.5121. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES